Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
A phase 1/2 trial of Cemiplimab in non-small-cell lung cancer and small-cell lung cancer, run by Servier Bio-Innovation LLC, active and no longer recruiting.
Overview
Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) is a phase 1/2 interventional study registered as NCT06162572 by Servier Bio-Innovation LLC, with 102 participants enrolled, started 2024-08-07 and due to reach its primary completion in 2027-04. Interventions recorded: S095018, S095024, S095029, S095018 Recommended Dose Expansion (RDE), S095024 RDE. Conditions listed: Non-small Cell Lung Cancer (NSCLC). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Ce
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialBlood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialNeoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialTHIO Sequenced With Cemiplimab in Advanced NSCLC
Shares Cemiplimab, Non-small-cell lung cancer.
- TrialA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult
Shares Cemiplimab, Small-cell lung cancer, Non-small-cell lung cancer.